Hypopituitarism (Panhypopituitarism) Clinical Presentation
- Author: Bernard Corenblum, MD, FRCPC; Chief Editor: Romesh Khardori, MD, PhD, FACP more...
Presentation varies from asymptomatic to acute collapse, depending on the etiology, rapidity of onset, and predominant hormones involved. Initially, a patient with any hormone deficiency may be asymptomatic. Individuals with the following deficiencies present with the indicated condition:
- ACTH deficiency - Adrenal (cortisol) insufficiency
- TSH deficiency - Hypothyroidism
- Gonadotropin deficiency -Hypogonadism
- GH deficiency - Failure to thrive and short stature in children; most adults are asymptomatic, but some may experience fatigue and weakness and decreased quality of life
- ADH deficiency - Polyuria and polydipsia
Other presenting features may be attributable to the underlying cause. A patient with a space-occupying lesion may present with headaches, double-vision, or visual-field deficits. A patient with large lesions involving the hypothalamus may present with polydipsia/polyuria or, rarely, syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Physical examination findings may be normal in subtle presentations. Patients may present with features attributable to deficiency of target hormones, including hypothyroidism (with a small, soft thyroid gland), adrenal insufficiency, hypogonadism (with small, soft testes in men), and failure to thrive.
In the stable patient, with the diverse complaints associated with hypopituitarism, a complete physical examination, including thyroid palpation, genital inspection, and ophthalmic examination, can support the diagnosis of hypopituitarism. During the neurologic and ophthalmic examinations, check specifically for visual acuity, extraocular movements, and bitemporal hemianopsia. Also look for evidence of hormonal hypersecretion due to a large functioning adenoma, such as signs of Cushing disease, acromegaly, or galactorrhea.
Kim SY. Diagnosis and Treatment of Hypopituitarism. Endocrinol Metab (Seoul). 2015 Dec. 30(4):443-55. [Medline]. [Full Text].
Schneider HJ, Schneider M, Saller B, et al. Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol. 2006 Feb. 154(2):259-65. [Medline].
Kokshoorn NE, Smit JW, Nieuwlaat WA, et al. Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study. Eur J Endocrinol. 2011 Aug. 165(2):225-31. [Medline].
Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab. 2011 Aug. 96(8):2330-40. [Medline]. [Full Text].
Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass JA. Radiation-induced hypopituitarism. Endocr Relat Cancer. 2009 Sep. 16(3):733-72. [Medline].
Fatemi N, Dusick JR, Mattozo C, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008 Oct. 63(4):709-18; discussion 718-9. [Medline].
Regal M, Paramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001 Dec. 55(6):735-40. [Medline].
Clayton RN. Mortality, cardiovascular events and risk factors in hypopituitarism. Growth Horm IGF Res. 1998 Feb. 8 Suppl A:69-76. [Medline].
O'Reilly MW, Reulen RC, Gupta S, et al. ACTH and gonadotropin deficiency predict mortality in patients treated for nonfunctioning pituitary adenoma (NFPA): long-term follow-up of 519 patients in two large European centres. Clin Endocrinol (Oxf). 2016 Jun 21. [Medline].
Bulow B, Hagmar L, Eskilsson J, Erfurth EM. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab. 2000 Feb. 85(2):574-84. [Medline].
Nakamoto J. Laboratory diagnosis of multiple pituitary hormone deficiencies: issues with testing of the growth and thyroid axes. Pediatr Endocrinol Rev. 2009 Jan. 6 Suppl 2:291-7. [Medline].
Li G, Shao P, Sun X, Wang Q, Zhang L. Magnetic resonance imaging and pituitary function in children with panhypopituitarism. Horm Res Paediatr. 2010. 73(3):205-9. [Medline].
Child CJ, Zimmermann AG, Woodmansee WW, et al. Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study. Eur J Endocrinol. 2011 Aug. 165(2):217-223. [Medline]. [Full Text].
Dutta P, Bhansali A, Singh P, et al. Congenital hypopituitarism: clinico-radiological correlation. J Pediatr Endocrinol Metab. 2009 Oct. 22(10):921-8. [Medline].
Lee MH, Lee JH, Seol HJ, et al. Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma. Brain Tumor Res Treat. 2016 Apr. 4(1):1-7. [Medline]. [Full Text].
Harsch IA, Schuller A, Hahn EG, Hensen J. Cortisone replacement therapy in endocrine disorders - quality of self-care. J Eval Clin Pract. 2010 Jun. 16(3):492-8. [Medline].
de Graaff LC, De Bellis A, Bellastella A, et al. Antipituitary antibodies in dutch patients with idiopathic hypopituitarism. Horm Res. 2009 Jan. 71(1):22-7. [Medline].
Welsh J. Managing hypopituitarism in emergency departments. Emerg Nurse. 2015 Oct 9. 23 (6):32-7. [Medline].
Silva PP, Bhatnagar S, Herman SD, Zafonte R, Klibanski A, Miller KK, et al. Predictors of Hypopituitarism in Patients with Traumatic Brain Injury. J Neurotrauma. 2015 Sep 29. [Medline].
Klose M, Feldt-Rasmussen U. Hypopituitarism in Traumatic Brain Injury-A Critical Note. J Clin Med. 2015 Jul 14. 4 (7):1480-97. [Medline].
Crespo I, Santos A, Webb SM. Quality of life in patients with hypopituitarism. Curr Opin Endocrinol Diabetes Obes. 2015 Aug. 22 (4):306-12. [Medline].